Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Guardian - UK
The Guardian - UK
Politics
Andrew Gregory Health editor

New drug could help thousands with chronic heart disease in England

Depiction of person with chest pain
HCM, which can occur in younger people who may formerly have had active lifestyles, until now has had no specific treatment targeting its underlying cause. Photograph: MattLphotography/Alamy

A first-of-its-kind treatment targeting a chronic heart disease could offer a “greater hope” to thousands of people living with the condition.

The National Institute for Health and Care Excellence (Nice) has approved the use of mavacamten in draft guidance to the NHS. It would be used to treat those with obstructive hypertrophic cardiomyopathy (HCM), with about 7,000 people expected to benefit.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.